Morphologic and molecular prognostic markers in prostate cancer

被引：29
|
作者：
Ross, JS [1 ]
Sheehan, CE
Dolen, EM
Kallakury, BVS
机构：
[1] Albany Med Coll, Dept Pathol & Lab Med, Albany, NY 12208 USA
[2] Albany Med Coll, Dept Radiol, Albany, NY 12208 USA
[3] Millennium Pharmaceut Inc, Cambridge, MA USA
[4] Georgetown Univ, Sch Med, Dept Pathol, Georgetown, MD USA
来源：
ADVANCES IN ANATOMIC PATHOLOGY | 2002年 / 9卷 / 02期
关键词：
prostate cancer; biomarker; prognosis; grade; stage; DNA ploidy; cell proliferation; oncogene; cell adhesion; HER-2/neu; apoptosis; proteasome;
D O I：
10.1097/00125480-200203000-00003
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
In this review, a series of traditional morphology-based measurements, relatively well-documented ancillary biomarkers, and emerging molecular assays are evaluated for their relative ability to predict prognosis in prostate cancer. Prognostic factors that have achieved widespread use and are classified as category I by the College of American Pathologists' Solid Tumor Prognostic Factor Consensus Conference are compared with newer tests that are beginning to be used in clinical practice (category II) and emerging molecular-based assays that have yet to be widely validated in the published literature or in clinical trials (category III).
引用
收藏
页码：115 / 128
页数：14
相关论文
共 50 条
  • [31] Epigenetic markers for molecular detection of prostate, cancer
    Costa, Vera L.
    Henrique, Rui
    Jeronimo, Carmen
    DISEASE MARKERS, 2007, 23 (1-2) : 31 - 41
  • [32] Molecular prognostic markers of urine bladder cancer
    Pavlov, V. N.
    Izmailov, A. A.
    Akhmadishina, L. Z.
    Victorova, T. V.
    Izmailova, S. M.
    Urmantsev, M. F.
    Alekseev, A. V.
    Zagitov, A. R.
    Kutliyarov, L. M.
    ONKOUROLOGIYA, 2012, 8 (02): : 32 - 36
  • [33] Diagnostic and prognostic molecular biomarkers for prostate cancer
    Kristiansen, Glen
    HISTOPATHOLOGY, 2012, 60 (01) : 125 - 141
  • [34] Molecular biomarkers and prognostic factors for prostate cancer
    Kretschmer, A.
    Tolkach, Y.
    Ellinger, J.
    Kristiansen, G.
    UROLOGE, 2017, 56 (07): : 933 - 943
  • [35] Molecular markers in urologic oncology: prostate cancer
    Reichard, Chad A.
    Stephenson, Andrew J.
    Klein, Eric A.
    CURRENT OPINION IN UROLOGY, 2016, 26 (03) : 225 - 230
  • [36] The prognostic value of inducible nitric oxide synthase in local prostate cancer
    Aaltomaa, SH
    Lipponen, PK
    Viitanen, J
    Kankkunen, JP
    Ala-Opas, MY
    Kosma, VM
    BJU INTERNATIONAL, 2000, 86 (03) : 234 - 239
  • [37] Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer
    Huang, Xiaoyi
    Yuan, Tiezheng
    Liang, Meihua
    Du, Meijun
    Xia, Shu
    Dittmar, Rachel
    Wang, Dian
    See, William
    Costello, Brian A.
    Quevedo, Fernando
    Tan, Winston
    Nandy, Debashis
    Bevan, Graham H.
    Longenbach, Sherri
    Sun, Zhifu
    Lu, Yan
    Wang, Tao
    Thibodeau, Stephen N.
    Boardman, Lisa
    Kohli, Manish
    Wang, Liang
    EUROPEAN UROLOGY, 2015, 67 (01) : 33 - 41
  • [38] Clinically Relevant Prognostic Markers for Prostate Cancer: The Search Goes On
    Gelmann, Edward P.
    Henshall, Susan M.
    ANNALS OF INTERNAL MEDICINE, 2009, 150 (09) : 647 - U17
  • [39] Molecular prognostic markers in locally advanced colon cancer
    Lurje, Georg
    Zhang, Wu
    Lenz, Heinz-Josef
    CLINICAL COLORECTAL CANCER, 2007, 6 (10) : 683 - 690
  • [40] Molecular prognostic markers in pancreatic cancer: A systematic review
    Garcea, G
    Neal, CP
    Pattenden, CJ
    Steward, WP
    Berry, DP
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (15) : 2213 - 2236
12345